✦ LIBER ✦

Prospective metastatic risk assignment in clinical stage I nonseminomatous germ cell testis cancer: a single institution pilot study☆

✍ Scribed by Michael Perrotti; Murali Ankem; Anita Bancilla; Victor deCarvalho; Peter Amenta; Robert Weiss

Book ID: 116955599
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 51 KB
Volume: 22
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2004.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Complications of Primary Nerve Sparing R

Complications of Primary Nerve Sparing Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Experience of the German Testicular Cancer Study Group

✍ HEIDENREICH, A; ALBERS, P; HARTMANN, M; KLIESCH, S; KOHRMANN, K; KREGE, S; LOSSI 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 76 KB

CONTEMPORARY SERIES OF OPEN AND LAPAROSC

CONTEMPORARY SERIES OF OPEN AND LAPAROSCOPIC RETROPERITONEAL LYMPH-NODE DISSECTION (RPLND) IN CLINICAL STAGE I NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS (NSGCTS): DATA FROM A SINGLE INSTITUTION

✍ Nicolai, Nicola; Biasoni, Davide; Aguilera, Jhonny Piedra; Necchi, Andrea; Piva, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 118 KB

798 ORAL A prospective study of 18FDG PE

798 ORAL A prospective study of 18FDG PET in the prediction of relapse in patients with high risk clinical stage I non-seminomatous germ cell cancer (MRC study TE22)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 293 KB

MP10-09 FIFTEEN YEARS AFTER TREATMENT WI

MP10-09 FIFTEEN YEARS AFTER TREATMENT WITH ONE ADJUVANT CYCLE OF ETOPOSIDE, BLEOMYCIN AND CISPLATIN CHEMOTHERAPY OUTCOMES IN PATIENTS WITH HIGH RISK NONSEMINOMATOUS GERM CELL TUMORS CLINICAL STAGE I. EXTENDED FOLLOW UP OF A PROSPECTIVE SINGLE ARM CLINICAL TRIAL COHORT

✍ Vidal Faune, Alvaro; Thalmann, George N.; Fey, Martin; Studer, Urs E. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

Randomized Phase III trial comparing ret

Randomized Phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical Stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group: Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group, Department of Urology, Klinikum Kassel GmbH, Kassel, Germany

✍ Donald L. Trump 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB